Simultaneous analysis of furosemide and bumetanide in horse plasma using high performance liquid chromatography.

The research article is about the development of a method using high performance liquid chromatography to simultaneously analyse the presence of furosemide and bumetanide in horse plasma.

Objective and Methodology

• The main purpose of this study was to create an efficient method for the simultaneous detection and analysis of two drugs – furosemide and bumetanide – in horse plasma.
• The research used high performance liquid chromatography (HPLC), a technique used to separate, identify, and quantify each component in a mixture of substances.
• The specific setup for the HPLC involved a reversed phase column, known for its beneficial characteristic of separating a broad range of components. Particularly, the C8 (3 microns) reversed phase column was utilized, which is a specific type size and structure of a column used in chromatography.

Findings

• The method developed proved efficient, providing clear separation of the two drugs from other substances present in the horse plasma.
• The detection limit, or the smallest quantity of these drugs that can be reliably measured by the method, was defined as 10 nanograms per milliliter (ng/mL). This means any quantity below 10 ng/mL may not be accurately detected or may go unnoticed.
• The study also demonstrated the stability of these drugs in plasma at both natural and acidic pH levels for a time period of up to 24 hours.

Implication of the Study

• The developed method can be used to detect furosemide levels in plasma samples taken from horses receiving a therapeutic dose of furosemide.
• This method could potentially be helpful in confirming the administration of either furosemide or bumetanide. Detecting such compounds in the plasma of race horses, for example, could play a critical role in enforcing rules against performance-enhancing drugs.